A message from Michigan Medicine leaders

January 17, 2022  //  FOUND IN: Strategy & Leadership

Dear colleagues,

We want to share with you news that was conveyed by the board of regents this weekend: Regents’ decision.

Following an investigation by the regents into an allegation of an inappropriate relationship between President Mark Schlissel and a subordinate, the board of regents removed President Schlissel from his post effective immediately.

While this news is very difficult, it does not change the strategic path forward for Michigan Medicine. We will continue to advance our culture of accountability, while elevating our tripartite mission. In the midst of this news and the challenges of the ongoing pandemic, we remain steadfast in our commitment to caring for patients, educating learners and focusing on research and discovery.

We are fortunate that former President Mary Sue Coleman will immediately serve as interim president while a search is conducted for a new leader. President Coleman will provide the stability and continuity of leadership that is needed at this time.

The entire Michigan Medicine leadership team remains firmly committed to preventing sexual and gender-based misconduct and offering support to those who have been harmed with a comprehensive program. A website with tools and resources is available at https://sexualmisconduct.umich.edu/.

This news is deeply troubling for all of us, and we appreciate your continued dedication to our mission and values.


Marschall S. Runge, M.D., Ph.D.
Executive Vice President for Medical Affairs
CEO, Michigan Medicine

Steven L. Kunkel, Ph.D.
Executive Vice Dean for Research, U-M Medical School
Chief Scientific Officer, Michigan Medicine

David C. Miller, M.D., M.P.H.
President, U-M Health
Executive Vice Dean for Clinical Affairs, U-M Medical School

Debra Weinstein, M.D.
Executive Vice Dean for Academic Affairs, U-M Medical School
Chief Academic Officer, Michigan Medicine